Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-08-02
2011-08-02
Kim, Jennifer M (Department: 1628)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
Reexamination Certificate
active
07989479
ABSTRACT:
The use of 6-(S-Cyclopropylcarbamoyl-S-fluoro-2-methyl-phenyl)-N-(2,2-dimethylproyl)-nicotinamide, which is known in the art as a p38 kinase inhibitor in the treatment or prophlaxis of one or more psychiatric disorders.
REFERENCES:
patent: 7125898 (2006-10-01), Aston et al.
patent: 7151118 (2006-12-01), Angell et al.
patent: 7166623 (2007-01-01), Angell et al.
patent: 7183297 (2007-02-01), Angell et al.
patent: 7208629 (2007-04-01), Angell et al.
patent: 7271289 (2007-09-01), Aston
patent: 7309800 (2007-12-01), Angell et al.
patent: 7384963 (2008-06-01), Angell et al.
patent: 7396843 (2008-07-01), Angell et al.
patent: 7425555 (2008-09-01), Angell et al.
patent: 7432289 (2008-10-01), Angell et al.
patent: 2005/0065195 (2005-03-01), Angell et al.
patent: 2006/0122221 (2006-06-01), Angell et al.
patent: 2006/0264479 (2006-11-01), Aston et al.
patent: 2006/0276516 (2006-12-01), Aston et al.
patent: 2007/0054942 (2007-03-01), Patel et al.
patent: 2007/0105850 (2007-05-01), Aston
patent: 2007/0112046 (2007-05-01), Angell et al.
patent: 2007/0129354 (2007-06-01), Aston et al.
patent: 2007/0142372 (2007-06-01), Campos et al.
patent: 2007/0142476 (2007-06-01), Angell et al.
patent: 2007/0161684 (2007-07-01), Walker
patent: 2008/0051416 (2008-02-01), Boehm et al.
patent: 2008/0214623 (2008-09-01), Chandi et al.
patent: WO 03/068747 (2003-08-01), None
patent: WO 03/097062 (2003-11-01), None
patent: WO 2007/147103 (2007-12-01), None
patent: WO 2007/147104 (2007-12-01), None
patent: WO 2007/147109 (2007-12-01), None
The Merck Index, Merck & Co., 13thEdition, Whitehouse Station, NJ p. 12 (2001).
Corsi Mauro
Faiferman Isidore
Pich Emilio Merlo
Ratti Emiliangelo
Wren Paul Bryan
GlaxoSmithKline LLC
Kim Jennifer M
Riek James P.
LandOfFree
Use of a p38 kinase inhibitor for treating psychiatric... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of a p38 kinase inhibitor for treating psychiatric..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of a p38 kinase inhibitor for treating psychiatric... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2652247